Cargando…

Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment

Pancreatic cancer (PC) is one of the most common malignancies and also a leading cause of cancer-related mortality worldwide. Many studies have shown that epidermal growth factor receptor (EGFR) is highly expressed in PC, which provides a potential target for PC treatment. However, EGFR inhibitors u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Shihui, Zheng, Hailun, Ye, Jinyao, Huang, Huirong, Zhou, Bin, Yao, Qing, Lin, Guangyong, Zhang, Hailin, Kou, Longfa, Chen, Ruijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017486/ https://www.ncbi.nlm.nih.gov/pubmed/33815107 http://dx.doi.org/10.3389/fphar.2021.625084

Ejemplares similares

Alantolactone-loaded chitosan/hyaluronic acid nanoparticles suppress psoriasis by deactivating STAT3 pathway and restricting immune cell recruitment
por: Chen, Ruijie, et al.
Publicado: (2022)

Bilirubin Protects Transplanted Islets by Targeting Ferroptosis
por: Yao, Qing, et al.
Publicado: (2020)

Selective STAT3 Inhibitor Alantolactone Ameliorates Osteoarthritis via Regulating Chondrocyte Autophagy and Cartilage Homeostasis
por: Pei, Wenbin, et al.
Publicado: (2021)

Alantolactone Enhances the Phagocytic Properties of Human Macrophages and Modulates Their Proinflammatory Functions
por: Gierlikowska, Barbara, et al.
Publicado: (2020)

Drug discovery and formulation development for acute pancreatitis
por: Jiang, Xue, et al.
Publicado: (2020)

Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer
por: Cai, Yuan, et al.
Publicado: (2021)

Drug-loaded PEG-PLGA nanoparticles for cancer treatment
por: Zhang, Dan, et al.
Publicado: (2022)

Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy
por: Kou, Longfa, et al.
Publicado: (2019)

Carbidopa suppresses prostate cancer via aryl hydrocarbon receptor-mediated ubiquitination and degradation of androgen receptor
por: Chen, Zhiwei, et al.
Publicado: (2020)

Alantolactone Improves Prolonged Exposure of Interleukin-6-Induced Skeletal Muscle Inflammation Associated Glucose Intolerance and Insulin Resistance
por: Kim, Minjee, et al.
Publicado: (2017)

Preparation and Release Profiles in Vitro/Vivo of Galantamine Pamoate Loaded Poly (Lactideco-Glycolide) (PLGA) Microspheres
por: Du, Liping, et al.
Publicado: (2021)

Formulation and In vitro Interaction of Rhodamine-B Loaded PLGA Nanoparticles with Cardiac Myocytes
por: Jonderian, Antranik, et al.
Publicado: (2016)

Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer
por: Fu, Zhiwen, et al.
Publicado: (2022)

Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
por: Shi, Lingyi, et al.
Publicado: (2017)

Resetting amino acid metabolism of cancer cells by ATB(0,+)-targeted nanoparticles for enhanced anticancer therapy
por: Kou, Longfa, et al.
Publicado: (2021)

CD44/Folate Dual Targeting Receptor Reductive Response PLGA-Based Micelles for Cancer Therapy
por: Zhang, Ru, et al.
Publicado: (2022)

Design, Synthesis, and Antitumor Activity of Erlotinib Derivatives
por: Mao, Long-fei, et al.
Publicado: (2022)

Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading
por: Han, Felicity Y., et al.
Publicado: (2016)

Triggering of Programmed Erythrocyte Death by Alantolactone
por: Alzoubi, Kousi, et al.
Publicado: (2014)

The role of transporters in cancer redox homeostasis and cross-talk with nanomedicines
por: Kou, Longfa, et al.
Publicado: (2020)

Curcumin-Loaded mPEG-PLGA Nanoparticles Attenuates the Apoptosis and Corticosteroid Resistance Induced by Cigarette Smoke Extract
por: Chen, Xi, et al.
Publicado: (2022)

Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer
por: Tang, Z, et al.
Publicado: (2008)

Mechanism of miR-30b-5p-Loaded PEG-PLGA Nanoparticles for Targeted Treatment of Heart Failure
por: Ren, Yu, et al.
Publicado: (2021)

Synthesis and appraisal of dalbergin-loaded PLGA nanoparticles modified with galactose against hepatocellular carcinoma: In-vitro, pharmacokinetic, and in-silico studies
por: Gautam, Anurag Kumar, et al.
Publicado: (2022)

PLGA: the smart therapeutics goods carrier
por: Poojari, Radhika J.
Publicado: (2013)

PLGA-Based Nanoparticles in Cancer Treatment
por: Rezvantalab, Sima, et al.
Publicado: (2018)

Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
por: Kou, Longfa, et al.
Publicado: (2018)

Erlotinib Resistance in Lung Cancer: Current Progress and Future Perspectives
por: Tang, Joy, et al.
Publicado: (2013)

Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone
por: Rasul, Azhar, et al.
Publicado: (2013)

Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage
por: Huang, Huirong, et al.
Publicado: (2022)

Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC
por: Bahce, Idris, et al.
Publicado: (2016)

FGFC1 Selectively Inhibits Erlotinib-Resistant Non-Small Cell Lung Cancer via Elevation of ROS Mediated by the EGFR/PI3K/Akt/mTOR Pathway
por: Yan, Shike, et al.
Publicado: (2022)

EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
por: Choi, Hee-Jeong, et al.
Publicado: (2023)

Design, synthesis and biological evaluation of erlotinib-based IDO1 inhibitors
por: Hou, Xi-xi, et al.
Publicado: (2022)

Red Blood Cell Membrane-Camouflaged PLGA Nanoparticles Loaded With Basic Fibroblast Growth Factor for Attenuating Sepsis-Induced Cardiac Injury
por: Li, Xinze, et al.
Publicado: (2022)

Transporter-Targeted Nano-Sized Vehicles for Enhanced and Site-Specific Drug Delivery
por: Kou, Longfa, et al.
Publicado: (2020)

Alantolactone alleviates collagen-induced arthritis and inhibits Th17 cell differentiation through modulation of STAT3 signalling
por: Chen, Hsiang-Lai, et al.
Publicado: (2021)

Synthesis and Antitumor Activity of Erlotinib Derivatives Linked With 1,2,3-Triazole
por: Deng, Peng, et al.
Publicado: (2022)

Luteolin enhances erlotinib’s cell proliferation inhibitory and apoptotic effects in glioblastoma cell lines
por: Powe, Erika, et al.
Publicado: (2022)

Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles
por: Busari, Zulaikha A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h95316cvk8778353jpvb8si6u2